Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aventis
Pandemic influenza vaccine agreement signed
June 26th, 2004
Aventis has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), to produce an investigational influenza vaccine based on a potential pandemic virus strain. Aventis Pasteur, the human vaccines business of Aventis, has agreed to produce 8000 doses based on two pilot lots of vaccine containing an H5N1 influenza virus strain - the so-called avian strain - that circulated in Southeast Asia late last year. "Last year's outbreak of avian influenza served as a stark reminder that an influenza pandemic remains a real threat," said David J. Williams, chairman...
Source: Law & Health Weekly (2004-06-26)
|
